doi: 10.3389/fendo.2024.1379228 Received 30 January 2024 Accepted 08 April 2024 Published 30 April 2024 Volume 15 - 2024 Edited by Fabrizio Barbetti, University of Rome Tor Vergata, Italy Reviewed by Xavier Prieur, INSERM U1087 Institut du Thorax, France Joseph Polex-Wolf, Novo Nordisk, Denmark Updates Copyright 2024 Roumane, Mcilroy, Sommer, Han, Heisler and Rochford
The experimentation with GHK-Cu is associated with a tentative reduction in MDA levels and a possible restoration of GSH levels, suggesting a potential ameliorative action on oxidative stress
This is related to the rapid weight loss rather than the medication itself, a phenomenon called telogen effluvium that occurs with any significant weight loss
E., Hiatt, W
Simethicone the powerful compound behind the efficacy of Gas-X is a surfactant or anti-foaming agent